Stockscreener 앱 받기
12.44
3.58%
0.43
Orthofix Medical Inc 주식(OFIX)의 최신 뉴스
Synthetic Bone Graft Market Size Accelerating at 9.8% CAGR | - openPR.com
FDA Reclassifies Bone Growth Stimulators, Raising Competitive and Margin Pressures for Orthofix Medical - TipRanks
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights - PR Newswire
Orthofix Medical Q1 Earnings Call Highlights - Yahoo Finance
Orthofix Medical Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Orthofix (OFIX) Q1 2026 Earnings Transcript - AOL.com
Orthofix Q1 2026 presentation: commercial transitions complete, growth targets reaffirmed - Investing.com
Orthofix Medical Reports 79.3% Wider Q1 2026 Loss at -$0.52/Share - AlphaStreet
Orthofix Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Full Transcript: Orthofix Medical Q1 2026 Earnings Call - Benzinga
Orthofix Medical Posts Q1 2026 Growth, Narrows Losses - TipRanks
ORTHOFIX MEDICAL ($OFIX) Releases Q1 2026 Earnings - Quiver Quantitative
Orthofix: Q1 Earnings Snapshot - 10TV
Orthofix Medical : 1Q 2026 Earnings Call Presentation - marketscreener.com
Orthofix Medical Inc. Q1 2026 earnings preview - MSN
[10-Q] Orthofix Medical Inc. Quarterly Earnings Report - Stock Titan
Orthofix (NASDAQ: OFIX) posts Q1 2026 growth, narrows loss and maintains 2026 goals - Stock Titan
Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance - Business Wire
MSN Money - MSN
(OFIX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
[DEF 14A] Orthofix Medical Inc. Definitive Proxy Statement - Stock Titan
Orthofix Medical (OFIX) Expected to Announce Earnings on Tuesday - MarketBeat
Orthofix reshuffles spine division leadership, posts preliminary Q1 sales - MSN
How The Orthofix Medical (OFIX) Story Is Shifting After Q4 Models And 2026 Guidance - Yahoo Finance
Canaccord Genuity Reaffirms Their Buy Rating on Orthofix Medical (OFIX) - The Globe and Mail
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc.OFIX - marketscreener.com
How (OFIX) Movements Inform Risk Allocation Models - Stock Traders Daily
Orthofix to Report First Quarter 2026 Financial Results - Business Wire
Orthofix CLO Jorge Cedron sells $47,985 in company stock By Investing.com - Investing.com Australia
Orthofix CLO Jorge Cedron sells $47,985 in company stock - Investing.com
Orthofix Medical (OFIX) CLO sells shares for RSU tax obligations - Stock Titan
Top 11 Sternal Closure Systems in the World - IMARC Group
Orthofix Medical Inc. (NASDAQ:OFIX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Is Orthofix (OFIX) stock attracting cautious sentiment (Smart Money Active) 2026-04-18Trending Stock Ideas - UBND thành phố Hải Phòng
Orthofix (OFIX) Stock: Institutional Signals (Buying Pressure) 2026-04-18Retail Money Flow - Cổng thông tin điện tử tỉnh Lào Cai
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investi - GuruFocus
Street Watch: Is Orthofix Medical Inc part of any ETF2026 AllTime Highs & Daily Technical Stock Forecast Reports - baoquankhu1.vn
OFIX SEC FilingsOrthofix Med Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Closing: Does Orthofix Medical Inc have declining or rising EPSPortfolio Value Report & Verified Short-Term Plans - baoquankhu1.vn
OFIX: Barrington Research Maintains Outperform Rating and Price Target | OFIX Stock News - GuruFocus
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Orthofix Medical (NASDAQ:OFIX) Receives Outperform Rating from Barrington Research - MarketBeat
Bone Growth Stimulator Market size to exceed $2.83 Billion - openPR.com
Orthofix reports preliminary Q1 2026 net sales of USD 196.7M - Medical Buyer
Orthofix Realigns Spine Leadership to Strengthen Focus and Execution - BioSpace
0.41%
0.93%
자본화:
|
볼륨(24시간):